Crossword Solver > found answer > YMBION

×
×
How many letters in the Answer?

Welcome to Anagrammer Crossword Genius! Keep reading below to see if ymbion is an answer to any crossword puzzle or word game (Scrabble, Words With Friends etc). Scroll down to see all the info we have compiled on ymbion.

CROSSWORD
ANSWER

ymbion

Searching in Crosswords ...

The answer YMBION has 0 possible clue(s) in existing crosswords.

Searching in Word Games ...

The word YMBION is NOT valid in any word game. (Sorry, you cannot play YMBION in Scrabble, Words With Friends etc)

There are 6 letters in YMBION ( B3I1M3N1O1Y4 )

To search all scrabble anagrams of YMBION, to go: YMBION?

Rearrange the letters in YMBION and see some winning combinations

Dictionary
Game

note: word points are shown in red

Scrabble results that can be created with an extra letter added to YMBION

SYMBION BIONOMY

4 letters out of YMBION

BONY INBY MONY YONI

3 letters out of YMBION

BIN BIO BOY ION MIB MOB MON NIB NIM NOB NOM OBI YIN YOB YOM YON

2 letters out of YMBION

BI BO BY IN MI MO MY NO OI OM ON OY YO

Searching in Dictionaries ...

Definitions of ymbion in various dictionaries:

No definitions found

Word Research / Anagrams and more ...


Keep reading for additional results and analysis below.

Ymbion might refer to
YM BioSciences Inc. was a Canadian drug development company primarily focused on advancing CYT-387, an orally administered inhibitor of both the JAK1 and JAK2 kinases, which have been implicated in a number of hematological and immune cell disorders including myeloproliferative neoplasms and inflammatory diseases as well as certain cancers. YM BioSciences also had several preclinical programs underway with candidates from its library of compounds identified through internal research conducted at YM BioSciences Australia.
* The company also advanced other clinical-stage products, including Nimotuzumab, an EGFR-targeting monoclonal antibody, and CYT997, a vascular disrupting agent (VDA).
* The company was listed on the Toronto Stock Exchange and the New York Stock Exchange.YM BioSciences was the first company from any major-market country to enter into a relationship with the Cuban Government for the development of a number of that country's biopharmaceuticals, with first licenses concluding in 1995. In 1994, the company created a joint venture with Centro de Inmunología Molecular (CCIMAB) in Cuba called CIMYM BioSciences. The joint venture developed the Nimotuzumab drug. In February 2013, Gilead Sciences completed the acquisition of YM Biosciences for US $510 million.
Anagrammer Crossword Solver is a powerful crossword puzzle resource site. We maintain millions of regularly updated crossword solutions, clues and answers of almost every popular crossword puzzle and word game out there. We encourage you to bookmark our puzzle solver as well as the other word solvers throughout our site. Explore deeper into our site and you will find many educational tools, flash cards and plenty more resources that will make you a much better player. Ymbion: YM BioSciences Inc. was a Canadian drug development company primarily focused on advancing CYT-387, ...